Was the third quarter a case of “revenue in line, gross margin below expectations”?
- Camtek’s third-quarter revenue in 2026 was $161 million, up 28% year over year; it was above Goldman Sachs’ estimate of $159 million and slightly above the Visible Alpha consensus of $160 million. Non-GAAP earnings per share were $0.99, broadly in line with Goldman Sachs’ and market expectations.
- Gross margin, however, was 51.1%, below Goldman Sachs’ estimate of 52.0% and the market estimate of 52.2%. The company’s fourth-quarter revenue guidance was $180 million, above Goldman Sachs’ estimate of $177 million and the market estimate of $179 million; based on the company’s guidance, this represents year-over-year growth of 40.5%.
Why did Goldman Sachs sharply raise its 2027 forecast?
- At its Investor Day, management reiterated that revenue in 2027 would grow by about 35% and exceed $800 million. Based on this outlook, Goldman Sachs raised its 2027 revenue forecast from $699 million to $812 million, an increase of 16.1%; its non-GAAP earnings-per-share forecast rose from $4.30 to $4.95, an increase of 15.2%.
- The forecast upgrades are concentrated in 2027: Goldman Sachs raised its revenue forecast for 2026 only from $590 million to $598 million. If the adoption of chiplet architectures is significantly delayed, growth related to advanced packaging could be affected; Goldman Sachs listed this as one of the downside risks.
Can revenue growth translate into higher gross margins?
- Goldman Sachs attributed recent gross margin pressure to higher input costs in the third quarter. Despite raising its revenue forecasts, the firm lowered its gross margin forecast for 2027 from 52.8% to 52.0%; its forecast for 2026 was also reduced, from 51.9% to 51.1%.
- Goldman Sachs expects gross margins to recover gradually over the next several quarters, citing sales growth, improved cost efficiency, price increases, and a higher mix of higher-priced Hawk and Eagle G5 equipment. However, if price increases cannot be passed through, the path to improvement will be impeded.
Why was the price target cut despite higher earnings forecasts?
- Goldman Sachs cut its 12-month price target from $160 to $125. Its valuation keeps normalized earnings per share of $4.20 unchanged while lowering the price-to-earnings multiple from 38x to 30x, citing lower valuation multiples among peers. The company’s improved growth outlook did not offset the lower valuation assumption.
- Goldman Sachs maintained its Neutral rating, saying Camtek’s exposure to high-growth applications such as HBM and chiplets is attractive, but that the risk-reward is relatively balanced. Among semiconductor equipment peers, the firm prefers Applied Materials and Lam Research, both of which it expects to deliver revenue growth above 40% in 2026, driven primarily by etch and deposition equipment.